Biostatistics consulting can help at any stage of your trial

Our clinical trial statistical consulting gives sponsors direct access to senior biostatisticians when a statistical question comes up in their trial. That might be checking whether a sample size holds up, weighing an adaptive design, or answering a regulator’s question about your analysis.
Sponsors come to us at different stages, and we can help at any of them. The earlier we see the protocol, though, the more our advice can change. Once the endpoints are picked, the sample size is set, and the plan for handling missing data is locked in, our work shifts from shaping the design to working within it.
What do sponsors hire a statistical consultant for?
Design Stage
Trial Design Evaluation & Recommendations
Advising on the most appropriate design based on objectives, indication and constraints.
Protocol Review
Reviewing the statistical sections of your protocol and flagging what a regulator is likely to question.
Sample Size & Power Analysis Review
Checking the assumptions behind your sample size and making sure you can justify it to regulators and investors.
Endpoint Selection & Justification
Advising on which primary and secondary endpoints to use and when to measure them.
Adaptive Design Feasibility
Assessing whether an adaptive design fits your trial and how to structure it.
Running the trial
Enrollment Forecasting
Using publicly available registry data and proprietary tools to model recruitment timelines, identify enrollment challenges early, and support feasibility assessments.
Competitor Landscape
Advising how to design a trial to differentiate from competing studies in terms of endpoints, design, or evidence strength.
Real-World Evidence (RWE)
Incorporating RWE into trial planning to inform study design, support regulatory strategy, or augment trial results with real-world context.
When something goes wrong
Rescue Consultation on At-Risk Trials
Reviewing underperforming trials and advising on statistical fixes, such as redesign or re-powering.
Regulatory Meeting Preparation
Advising on statistical talking points, questions to anticipate, and documentation strategies for agency meetings or responses.
What does statistical consulting change in a clinical trial?
It changes the decisions that set your timeline, budget and submission. Those decisions come early: the design, the endpoints, the sample size and the analysis plan are usually settled before the first patient enrolls. Getting good advice at those points costs less than fixing the consequences later.
Here’s what that looks like in practice:
Fewer Protocol Amendments
Catching design problems before the protocol is final means fewer changes once sites are already running.
Clearer conversations with regulators
You go into agency meetings knowing which statistical questions to expect and how to answer them.
A sample size you can defend
We check the assumptions against prior studies and published evidence, so the trial isn’t underpowered or bigger than it needs to be.
Results that hold up
When the analysis is planned before the data comes in, the results are harder for regulators, partners or investors to challenge.
Clinical Trial Statistical Consulting
Why do sponsors choose EvoClinical for statistical consulting?
Deep Expertise
Decades of hands-on consulting experience with deep statistical knowledge relevant to numerous trial requirements.
Strategy First
We approach each engagement as advisors, not just service providers. Our consulting model is collaborative and transparent.
Therapeutic Diversity
From oncology to rare disease to CNS, we tailor strategies to your therapeutic area.
Cross-Functional Insight
We understand how statistics intersect with regulatory, operational, and therapeutic area needs.
Senior Talent Only
Your consulting engagement is led by our senior experts; all of whom have advised across successful submissions and therapeutic areas.
Regulatory Alignment
We don’t just know the stats; we know what regulators expect, and how to deliver it.
Select Case Studies
Certifications & Affiliations





Questions sponsors ask before hiring a statistical consultant
When should a sponsor bring in a statistical consultant?
As early as you can, ideally before the protocol is final. That’s when advice can still change the endpoints, the sample size and the analysis plan. But sponsors come to us at every stage: when drafting a protocol, after feedback from a regulator, or when a trial isn’t going to plan.
What's the difference between statistical consulting and statistical analysis?
Consulting is advice on decisions, such as which design fits your question, whether your sample size holds up, or how to answer a regulator. Statistical analysis is the execution: writing the analysis plan, building the datasets, and producing the tables and figures. Many sponsors start with consulting and move into analysis once the design is set.
Can you review a protocol or sample size calculation someone else wrote?
Yes. Protocol reviews and sample size reviews are two of our most common biostatistics consulting engagements. We check the assumptions, flag the risks, and tell you plainly what we’d change and why.
Can you help with an FDA or Health Canada meeting?
Yes. We help sponsors prepare the statistical side of agency meetings: the talking points, the questions to expect, and the documents that support your position.
Our trial is already running and something looks wrong. Can you still help?
Yes. We review underperforming trials and advise on statistical fixes, such as re-powering or adjusting the analysis approach. If the problem runs deeper, our clinical trial rescue service covers the statistics and data side in more detail.

